Efficacy of Definitive Radiotherapy for Base of Tongue Cancer Evaluated

Share this content:

the Cancer Therapy Advisor take:

According to a new study published in the American Journal of Clinical Oncology, the efficacy of definitive radiotherapy for the treatment of patients with base of the tongue cancer in a private practice setting is similar to that already published in the literature.

For the study, researchers sought to retrospectively investigate the efficacy of definitive radiotherapy alone or combined with chemotherapy for the treatment of patients with squamous cell carcinoma of the base of the tongue in a private practice.

Researchers identified 48 patients with squamous cell carcinoma of the base of the tongue who underwent definitive radiotherapy. All patients were followed for a median of 2.7 years, but living patients had a median follow-up of 4.9 years.

Two-thirds of patients received radiotherapy two times a day and the median overall duration of treatment was 45.5 days. Patients received a median total dose of 74.4 Gy. Comcomitant chemotherapy was given to 96% of patients and adjuvant chemotherapy was given to 58% of patients.

Results showed that at 5 years, those with T1 to T2 disease had a 91% local control rate, T3 had an 83% local control rate, and T4 had 12%. At 5 years, the overall survival rates for those with sate 1 to 2 disease were 67%, 56% for stage 3, 45% for stage 4A, and 33% for stage 4B.

Obesity Increases Risk of Death From Tongue Cancer
Efficacy of definitive radiotherapy for the treatment of patients with base of the tongue cancer in a private practice evaluated.
Objective of this study is to evaluate the efficacy of definitive radiotherapy (RT) for the treatment of base of the tongue cancer in a private practice. The data reveal that the local-regional control and overall survival rates after definitive RT were comparable with those in the literature.
READ FULL ARTICLE From Mdlinx

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs